Trial In Progress: Phase Ib/Ii Study Of Bcl-2/Bcl-Xl Inhibitor Pelcitoclax (Apg-1252) In Patients With Myelofibrosis (Mf) That Progressed After Initial Therapy
BLOOD(2020)
Abstract
Background:
MoreTranslated text
Key words
myelofibrosis,inhibitor
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined